Please login to the form below

Not currently logged in
Email:
Password:

clinical care

This page shows the latest clinical care news and features for those working in and with pharma, biotech and healthcare.

Social care crisis looms as demand to double by 2035

new solution to fix the already over-burdened social care system in England. ... An international comparison of long-term care funding and outcomes: insights for the social care green paper.

Latest news

More from news
Approximately 0 fully matching, plus 117 partially matching documents found.

Latest Intelligence

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    can measure clinical practice change and improved patient care. ... This means bringing the best measurement capability to each client solution: measuring barriers to behaviour change, clinical practice change metrics, clinical audit measures, patient

  • GDPR and the NHS ‘opt out’: a chance to engage patients in research GDPR and the NHS ‘opt out’: a chance to engage patients in research

    Increased global investment in clinical trials and real-world evidence studies would feed back directly into the economy and into NHS care.”. ... This shift fundamentally makes patients an active participant in their own care; allowing them to

  • The gold standard of scientific evidence The gold standard of scientific evidence

    In addition, healthcare practices participating in RCTs treat patients according to detailed protocols, making the care received in clinical trials unlikely to reflect what would be received in the real world. ... was subjected to more than 60 clinical

  • Tackling the challenge of non-adherence Tackling the challenge of non-adherence

    Tackling the challenge of non-adherence. Improving compliance requires empowering patients to be active partners in their own care. ... Studies have provided some interesting insights in this regard. For example, in a recent randomised clinical trial

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    The three forces behind the re-imagining of patient care. Understanding patient-centricity. ... Using apps to manage chronic conditions such as diabetes and asthma and rare disease such as pulmonary arterial hypertension can now be proven to improve

More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest appointments

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... He brings more than 30 years of clinical and

  • Hamell Communications adds to team Hamell Communications adds to team

    She has worked in regulatory affairs, psychiatric care and early phase clinical trials.

  • David Haslam takes over as NICE chair David Haslam takes over as NICE chair

    responsibilities. As current national clinical adviser to the Care Quality Commission, Prof Haslam will be aware of the new challenges NICE faces in its revised role as the bulk of NHS ... ensure better outcomes for patients in a rapidly changing health

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics